60例慢性阻塞性肺气肿合并肺心病的临床治疗分析

摘要

目的：通过探讨慢性阻塞性肺气肿合并肺心病的临床治疗方式,旨在为提高慢性阻塞性肺气肿合并肺心病的临床治疗有效率和患者生活质量提供理论依据。方法选择2013年1月~2014年1月在我院接受治疗的慢性阻塞性肺气肿合并肺心病患者60例,随机平均分成研究组和对照组两组,每组30例患者,对照组给予患者西药硝酸甘油、多巴酚丁胺治疗,研究组在对照组患者治疗的基础上给予中药定喘止咳汤治疗,比较治疗前后FEV1、FEV1/FVC、PaO2、PaCO2的变化情况。结果治疗后研究组患者FEV1为1545.21 ml、FEV1/FVC为68.36%、PaO2为82.18 mmHg、PaCO2为30.19 mmHg,研究组显著优于对照组,且<0.05差异有统计学意义。结论应用中西医结合治疗的方式治疗慢性阻塞性肺气肿合并肺心病能改善肺功能。%Objective To investigate the clinical treatment of chronic obstructive pulmonary heart disease emphysema, designed to improve the clinical treatment of chronic obstructive pulmonary emphysema, heart disease and provide a theoretical basis for ef iciency and quality of life of patients. Methods January 2013 -2014 in January in our hospital for treatment of 60 cases of chronic obstructive pulmonary emphysema, heart disease, were randomly divided into study group and control group, n=30 patients in the control group give patients medicine nitroglycerin, dobutamine treatment, research group was given cough medicine Dingchuan treated patients treated on the basis of the control group, before and after treatment FEV1, changes in FEV1/FVC, PaO2, PaCO2 Results After treatment, patients with FEV1 study group was 1545.21 ml, FEV1/FVC was 68.36%, PaO2 was 82.18 mmHg, PaCO2 was 30.19 mmHg, the study group was significantly bet er than the control group, and <0.05 difference was statistical y significant. Conclusion The combination therapy approach for treating chronic obstructive pulmonary emphysema and heart disease can improve lung function.